#CancerCareCollaboration

Roche Taiwan has partnered with TTY Biopharm Company Limited to improve cancer care in Taiwan. Starting from April 1st, TTY Biopharm will lead marketing efforts for Roche's Avastin® (Bevacizumab) in selected cancer areas, while Roche will continue to support clinical trials and research. The goal of this strategic alliance is to enhance cancer care and improve patient outcomes in Taiwan.

This partnership will primarily focus on addressing the most pressing cancer challenges in Taiwan.

With Roche's cancer treatment expertise and TTY Biopharm's local presence, this collaboration promises to bring innovative solutions to Taiwanese cancer patients.

Don't miss out on this groundbreaking collaboration! 

For more information, please visit: https://lnkd.in/gNQR-Q86

Follow #Globalbio for the latest biotech news and updates!